feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives",https://benzinga.com/general/biotech/22/06/27879636/the-daily-biotech-pulse-kezar-life-surges-on-positive-kidney-disease-trial-data-fda-rejects-spero,https://bit.ly/3QMCCVg
Benzinga,Kim Jong-Un Braces For Another Jolt To North Korea Economy Due To Anticipated Floods,https://benzinga.com/government/22/06/27875776/kim-jong-uns-covid-battered-economy-is-now-bracing-up-for-potential-floods,https://bit.ly/3Ns3eba
